Stephen Michael Kelsey Insider Trading $GERN GERON CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen Michael Kelsey.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen Michael Kelsey. Stephen Michael Kelsey is EVP, CMO, Oncology in GERON CORP ($GERN) and EVP, R&D Head, CMO in GERON CORP ($GERN) and See Remarks in Revolution Medicines, Inc. ($RVMD).
Stephen Michael Kelsey in GERON CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen Michael Kelsey: EVP, R&D Head, CMO, EVP, CMO, Oncology
Holdings: 473,122 shares
Current Value: $988,825
Latest Transaction: Jun 01 2012
$GERN Market Capitalization: $331.02M
$GERN Previous Close: $2.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stephen Michael Kelsey in GERON CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2012 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Sell | S | 1.37 | 9,300 | 12,741 | 473,122 | 482.4 K to 473.1 K (-1.93 %) |
| May 18 2012 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Option Exercise | A | 1.41 | 450,000 | 634,500 | 450,000 | |
| Jun 16 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Sell | S | 4.28 | 4,858 | 20,792 | 476,773 | 481.6 K to 476.8 K (-1.01 %) |
| May 24 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Option Exercise | A | 4.65 | 75,000 | 348,750 | 75,000 | |
| May 24 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Grant | A | 0.00 | 40,000 | 0 | 481,631 | 441.6 K to 481.6 K (+9.06 %) |
| May 24 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Grant | A | 0.00 | 40,000 | 0 | 441,631 | 401.6 K to 441.6 K (+9.96 %) |
| May 24 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, R&D Head, CMO | Grant | A | 0.00 | 37,500 | 0 | 401,631 | 364.1 K to 401.6 K (+10.30 %) |
| May 06 2011 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Sell | S | 4.83 | 14,163 | 68,407 | 364,131 | 378.3 K to 364.1 K (-3.74 %) |
| Jul 13 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Grant | A | 0.00 | 120,000 | 0 | 376,136 | 256.1 K to 376.1 K (+46.85 %) |
| Jul 13 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Grant | A | 0.00 | 20,000 | 0 | 256,136 | 236.1 K to 256.1 K (+8.47 %) |
| Jul 13 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Grant | A | 0.00 | 20,000 | 0 | 236,136 | 216.1 K to 236.1 K (+9.25 %) |
| Jul 13 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Grant | A | 0.00 | 140,000 | 0 | 216,136 | 76.1 K to 216.1 K (+183.88 %) |
| May 21 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Option Exercise | A | 5.29 | 75,000 | 396,750 | 75,000 | |
| May 21 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Grant | A | 0.00 | 37,500 | 0 | 73,793 | 36.3 K to 73.8 K (+103.33 %) |
| Apr 30 2010 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Sell | S | 5.66 | 3,707 | 20,982 | 36,293 | 40 K to 36.3 K (-9.27 %) |
| May 20 2009 | GERN | GERON CORP | Kelsey Stephen Michael | EVP, CMO, Oncology | Option Exercise | A | 6.76 | 200,000 | 1,352,000 | 200,000 |
Page: 1